Gonadotropin-releasing hormone neurosecretion in the human hypothalamus: in vitro regulation by dopamine

J Clin Endocrinol Metab. 1986 Mar;62(3):479-83. doi: 10.1210/jcem-62-3-479.

Abstract

An in vitro perifusion system was used to investigate GnRH release from adult human hypothalami in response to dopamine (DA) and the DA receptor antagonist haloperidol (HAL). Administration of a 1-microM pulse of DA consistently elicited a mean +/- SE 218 +/- 59% increase (P less than 0.05; n = 5) in GnRH release, whereas 1 microM HAL had no effect. Administration of 1 microM DA during three perifusions in which 1 microM HAL was added to the medium failed to alter basal GnRH release. In contrast, DA did evoke an acute 98 +/- 39% increase (P less than 0.06) in GnRH release during three matching perifusions with medium containing the alpha-adrenergic antagonist phentolamine. These studies demonstrate that DA can stimulate in vitro release of GnRH from the adult human hypothalamus by a DA receptor-mediated mechanism.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Aged
  • Dopamine / physiology*
  • Female
  • Gonadotropin-Releasing Hormone / metabolism*
  • Haloperidol / pharmacology
  • Humans
  • Hypothalamus / metabolism*
  • In Vitro Techniques
  • Male
  • Middle Aged
  • Perfusion

Substances

  • Gonadotropin-Releasing Hormone
  • Haloperidol
  • Dopamine